In the last 12 months, insiders at Prelude Therapeutics Inc ($PRLD) filed 71 transactions with the SEC: 15 open-market purchases totaling $876,166 and 0 sales totaling $0. Net insider sentiment: net buying.
Prelude Therapeutics Inc operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Vaddi Krishna (CEO) — 14 transactions totaling $698,740
- Combs Andrew (Chief Chemistry Officer) — 6 transactions totaling $154,788
- Huang Jane (President, CMO) — 26 transactions totaling $64,328
- Lim Bryant David (CLO, Interim CFO, Corp Sec.) — 2 transactions totaling $22,638
- Lim Bryant David (Chief Legal Officer, Corp Sec.) — 1 transaction totaling $0
View all SEC Filings for Prelude Therapeutics Inc (PRLD).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 76,132,337 | 9999.99% | 0.30% |
| Feb. 4, 2026 | Combs Andrew | Chief Chemistry Officer | A | Employee Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 76,132,337 | 9999.99% | 0.30% |
| Feb. 4, 2026 | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 837000 | $0.00 | 837,000.0000 | 76,132,337 | 9999.99% | 1.10% |
| Feb. 4, 2026 | Lim Bryant David | CLO, CFO, Corp Sec. | A | Employee Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 76,132,337 | 9999.99% | 0.36% |
| Nov. 5, 2025 | Sandor Victor | Not found | A | Director Stock Option (Right to Buy) | 121285 | $0.00 | 121,285.0000 | 76,132,337 | 9999.99% | 0.16% |
| Oct. 17, 2025 | Dorton Katina | Not found | A | Director Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 76,132,337 | 9999.99% | 0.10% |
| Oct. 4, 2025 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 90,272.0000 | 76,132,337 | 11.59% | 0.01% |
| Oct. 4, 2025 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 18,750.0000 | 76,132,337 | 33.33% | 0.01% |
| Oct. 4, 2025 | Huang Jane | President, CMO | F | Common Stock | 3355 | $1.47 | 86,917.0000 | 76,132,337 | 3.72% | 0.00% |
| July 4, 2025 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 28,125.0000 | 75,805,840 | 25.00% | 0.01% |
| July 4, 2025 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 84,252.0000 | 75,805,840 | 12.52% | 0.01% |
| July 4, 2025 | Huang Jane | President, CMO | F | Common Stock | 3355 | $0.79 | 80,897.0000 | 75,805,840 | 3.98% | 0.00% |
| June 12, 2025 | Bonita David P | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| June 12, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 76000 | $0.00 | 76,000.0000 | 75,805,840 | 9999.99% | 0.10% |
| June 12, 2025 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 76000 | $0.00 | 76,000.0000 | 75,805,840 | 9999.99% | 0.10% |
| June 12, 2025 | Sandor Victor | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| June 12, 2025 | Dier Mardi | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| June 12, 2025 | FRIEDMAN PAUL A | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| June 12, 2025 | Babler Martin | Not found | A | Director Stock Option (Right to Buy) | 38000 | $0.00 | 38,000.0000 | 75,805,840 | 9999.99% | 0.05% |
| April 4, 2025 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 78,232.0000 | 75,805,840 | 13.62% | 0.01% |
| April 4, 2025 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 37,500.0000 | 75,805,840 | 20.00% | 0.01% |
| April 4, 2025 | Huang Jane | President, CMO | F | Common Stock | 3355 | $0.68 | 74,877.0000 | 75,805,840 | 4.29% | 0.00% |
| March 25, 2025 | Vaddi Krishna | CEO | P | Common Stock | 675000 | $0.69 | 3,669,054.0000 | 75,805,840 | 22.54% | 0.89% |
| March 25, 2025 | Combs Andrew | Chief Chemistry Officer | P | Common Stock | 100000 | $0.69 | 480,123.0000 | 75,805,840 | 26.31% | 0.13% |
| March 21, 2025 | Vaddi Krishna | CEO | P | Common Stock | 15000 | $0.73 | 2,994,054.0000 | 75,805,840 | 0.50% | 0.02% |
| March 20, 2025 | Vaddi Krishna | CEO | P | Common Stock | 5416 | $0.73 | 2,979,054.0000 | 75,805,840 | 0.18% | 0.01% |
| March 14, 2025 | Vaddi Krishna | CEO | P | Common Stock | 29999 | $0.75 | 2,964,532.0000 | 75,805,840 | 1.02% | 0.04% |
| March 17, 2025 | Vaddi Krishna | CEO | P | Common Stock | 9106 | $0.75 | 2,973,638.0000 | 75,805,840 | 0.31% | 0.01% |
| March 13, 2025 | Vaddi Krishna | CEO | P | Common Stock | 50000 | $0.72 | 2,934,533.0000 | 75,805,840 | 1.73% | 0.07% |
| March 12, 2025 | Vaddi Krishna | CEO | P | Common Stock | 47500 | $0.71 | 2,884,533.0000 | 75,805,840 | 1.67% | 0.06% |
| Feb. 4, 2025 | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 496000 | $0.00 | 496,000.0000 | 75,805,840 | 9999.99% | 0.65% |
| Feb. 4, 2025 | Lim Bryant David | CLO, CFO, Corp Sec. | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 75,805,840 | 9999.99% | 0.26% |
| Feb. 4, 2025 | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 75,805,840 | 9999.99% | 0.23% |
| Feb. 4, 2025 | Combs Andrew | Chief Chemistry Officer | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 75,805,840 | 9999.99% | 0.23% |
| Feb. 4, 2025 | Huang Jane | President, CMO | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 75,805,840 | 9999.99% | 0.26% |
| Jan. 4, 2025 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 46,875.0000 | 75,805,840 | 25.00% | 0.01% |
| Jan. 4, 2025 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 72,716.0000 | 75,805,840 | 14.80% | 0.01% |
| Jan. 4, 2025 | Huang Jane | President, CMO | F | Common Stock | 3859 | $1.39 | 68,857.0000 | 75,805,840 | 5.31% | 0.01% |
| Dec. 31, 2024 | Vaddi Krishna | CEO | P | Common Stock | 5000 | $1.21 | 2,837,033.0000 | 75,855,949 | 0.18% | 0.01% |
| Dec. 30, 2024 | Vaddi Krishna | CEO | P | Common Stock | 10000 | $1.20 | 2,832,043.0000 | 75,855,949 | 0.35% | 0.01% |
| Dec. 23, 2024 | Combs Andrew | Chief Chemistry Officer | P | Common Stock | 60000 | $1.37 | 377,623.0000 | 75,855,949 | 18.89% | 0.08% |
| Dec. 20, 2024 | Combs Andrew | Chief Chemistry Officer | P | Common Stock | 3075 | $1.15 | 317,623.0000 | 75,855,949 | 0.98% | 0.00% |
| Dec. 19, 2024 | Vaddi Krishna | CEO | P | Common Stock | 6888 | $0.89 | 2,822,043.0000 | 75,855,949 | 0.24% | 0.01% |
| Dec. 18, 2024 | Vaddi Krishna | CEO | P | Common Stock | 100000 | $0.93 | 2,822,043.0000 | 75,855,949 | 3.67% | 0.13% |
| Dec. 19, 2024 | Lim Bryant David | CLO, Interim CFO, Corp Sec. | P | Common Stock | 25000 | $0.91 | 27,400.0000 | 75,855,949 | 1041.67% | 0.03% |
| Oct. 4, 2024 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 66,690.0000 | 75,855,949 | 16.36% | 0.01% |
| Oct. 4, 2024 | Huang Jane | President, CMO | F | Common Stock | 3349 | $2.00 | 63,341.0000 | 75,855,949 | 5.02% | 0.00% |
| Oct. 4, 2024 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 56,250.0000 | 75,855,949 | 14.29% | 0.01% |
| July 4, 2024 | Huang Jane | President, CMO | F | Common Stock | 3347 | $3.60 | 57,315.0000 | 60,357,052 | 5.52% | 0.01% |
| July 4, 2024 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 65,625.0000 | 60,357,052 | 12.50% | 0.02% |
| July 4, 2024 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 60,662.0000 | 60,357,052 | 18.28% | 0.02% |
| June 14, 2024 | FRIEDMAN PAUL A | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | Dier Mardi | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | Bonita David P | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | Babler Martin | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | BAKER BROS. ADVISORS LP | Not found | A | Non- Qualified Stock Option (right to buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| June 14, 2024 | Sandor Victor | Not found | A | Director Stock Option (Right to Buy) | 23500 | $0.00 | 23,500.0000 | 60,357,052 | 9999.99% | 0.04% |
| May 14, 2024 | Lim Bryant David | CLO, Interim CFO, Corp Sec. | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 60,357,052 | 9999.99% | 0.04% |
| April 4, 2024 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 54,634.0000 | 60,357,052 | 20.71% | 0.02% |
| April 4, 2024 | Huang Jane | President, CMO | F | Common Stock | 3347 | $4.74 | 51,287.0000 | 60,357,052 | 6.13% | 0.01% |
| April 4, 2024 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 75,000.0000 | 60,357,052 | 11.11% | 0.02% |
| March 1, 2024 | Huang Jane | President, CMO | A | Employee Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 60,357,052 | 9999.99% | 0.29% |
| March 1, 2024 | Scherle Peggy | Chief Scientific Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |
| March 1, 2024 | Lim Bryant David | Chief Legal Officer, Corp Sec. | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |
| March 1, 2024 | Combs Andrew | Chief Chemistry Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |
| March 1, 2024 | Chardonnet Laurent | Chief Financial Officer | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |
| March 1, 2024 | Vaddi Krishna | CEO | A | Employee Stock Option (right to buy) | 425000 | $0.00 | 425,000.0000 | 60,357,052 | 9999.99% | 0.70% |
| Jan. 4, 2024 | Huang Jane | President, CMO | M | Restricted Stock Unit | 9375 | $0.00 | 84,375.0000 | 60,357,052 | 10.00% | 0.02% |
| Jan. 4, 2024 | Huang Jane | President, CMO | F | Common Stock | 3844 | $3.77 | 45,259.0000 | 60,357,052 | 7.83% | 0.01% |
| Jan. 4, 2024 | Huang Jane | President, CMO | M | Common Stock | 9375 | $0.00 | 49,103.0000 | 60,357,052 | 23.60% | 0.02% |